Natalya Gankina

Statistics

Publications

Citations

133

H-Index

Active since

2018

Affiliations

Regional Center for Prevention and Control of AIDS and Infectious Diseases(Current)

Gilead Sciences (United States)

Sechenov University

Natalya Gankina is an author at Regional Center for Prevention and Control of AIDS and Infectious Diseases specializing in pharmacotherapy, antiviral therapy, and viral hepatitis.

Publications per year

2018–2024

Publications

Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial

Cissy Kityo, Debbie Hagins, Ellen Koenig et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2019 · 56 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B

Maria Buti, Jeong Heo, Yasuhito Tanaka et al. · Journal of Hepatology · 2024 · 49 citations · Full text

Pharmacy, Pharmacotherapy, Hepatitis Pharmacotherapy +14

Sofosbuvir/velpatasvir for the treatment of HCV: excellent results from a phase-3, open-label study in Russia and Sweden

Vladimir Chulanov, Dzhamal Abdurakhmanov, Eduard Burnevich et al. · Infectious Diseases · 2018 · 15 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Prevalence of resistance-associated substitutions and phylogenetic analysis of hepatitis C virus infection in Russia

Charlotte Hedskog, Joel O. Wertheim, Reilly Hostager et al. · International Journal of Infectious Diseases · 2021 · 13 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +17

1–4 of 4